July 24 (Reuters) - Medical device maker Boston
Scientific ( BSX ) beat analysts' estimates for second-quarter
profit on Wednesday, helped by strong demand for its heart
devices.
On an adjusted basis, Boston Scientific ( BSX ) earned 62 cents per
share in the second quarter, compared with estimates of 58
cents, according to LSEG data.